Desvenlafaxine in the treatment of major depressive disorder
Maria Teresa C Lourenco1, Sidney H Kennedy1,21Department of Psychiatry, University Health Network, Toronto; 2Department of Psychiatry, University of Toronto, Toronto, CanadaAbstract: Major depressive disorder (MDD) is among the most incapacitating conditions in the world. The emergence of the select...
Saved in:
Main Authors: | Maria Teresa C Lourenco1, Sidney H Kennedy1,2 |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2009
|
Subjects: | |
Online Access: | https://doaj.org/article/8043b3d2f9754bdfbcbd3a07a856cddc |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative efficacy of escitalopram in the treatment of major depressive disorder
by: Mazen K Ali, et al.
Published: (2011) -
Augmentation treatment in major depressive disorder: focus on aripiprazole
by: J Craig Nelson, et al.
Published: (2008) -
Levomilnacipran for the treatment of major depressive disorder: a review
by: Asnis GA, et al.
Published: (2015) -
Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder
by: Alvarez E, et al.
Published: (2014) -
Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder
by: Aoki A, et al.
Published: (2014)